Center on Health Equity & Access
Clinical
Health Care Cost
Health Care Delivery
Insurance
Policy
Technology
Value-Based Care

Free In-Person Regional Events Focused on Oncology and Population Health

All Coverage Event Coverage Interviews News

AJMC Journals Anniversary Author Forms Authors Nominate a Rising Leader Submit a Manuscript

Oncology

Latest News

The investigators found that tumor mutational burden and PD-L1 expression, which have traditionally been used as indicators of immunotherapy efficacy, had little predictive value for survival in this cohort. | Image credit: Dragana Gordic - stock.adobe.com

Predictive Model Forecasts Advanced NSCLC Outcomes

By Jared Kaltwasser

August 14th 2025

The newly developed model has an area under the curve of 0.807 for predicting progression-free survival.

Dordaviprone is indicated for recurrent H3 K27M-mutant diffuse midline glioma, an ultra-rare, aggressive brain tumor primarily affecting children. | Image credit: wladimir1804 - stock.adobe.com

FDA Approves Dordaviprone as First and Only Treatment for Aggressive Form of Glioma

By Rose McNulty

August 6th 2025

Gen Li, PhD, MBA, president and founder of Phesi

Real-World Data, Digital Patient Profiles Are Revolutionizing Trial Design, Patient Recruitment: Gen Li, PhD, MBA

By Pearl Steinzor
Gen Li, PhD, MBA

August 4th 2025

Value-based care. | Image Credit: irissca - stock.adobe.com

Legal Navigation Services Key to Addressing Disparities in Cancer Care

By Cameron Santoro

July 31st 2025

Radiotherapy can work synergistically with immunotherapy by reprogramming the tumor microenvironment. | Image credit: Crystallight-stock.adobe.com

Brain Radiotherapy Plus ICIs Boost Survival in SCLC With Brain Metastases

By Jared Kaltwasser

July 30th 2025

Latest CME Events & Activities

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

N.J. Cancer Docs Form Network

January 30th 2012

Prostate Cancer Screenings: The Debate Continues

January 30th 2012

Researchers who set off a firestorm in 2009 when they questioned the need for all adult men to undergo annual prostate cancer screenings have updated their findings.

Prostate Cancer Study Proves Drug Delays Disease Progression

January 24th 2012

New Test Offers Greater Accuracy in Early Detection of Colorectal Cancer

January 20th 2012

Dr. Adil Daud Discusses Zelboraf and Yervoy for the Treatment of Metastatic Melanoma

January 19th 2012

Systematic Review of Comparative Effectiveness Data for Oncology Orphan Drugs

Mindy M. Cheng, MS;Scott D. Ramsey, MD, PhD;Emily Beth Devine, PharmD, MBA, PhD;Louis P. Garrison, PhD;Brian W. Bresnahan, PhD;David L. Veenstra, PharmD, PhD

January 19th 2012

This study critically assessed the published clinical and economic evidence supporting oncology orphan drugs marketed in the United States.

Dr. Michelle Melisko Discusses Access to Care for Breast Cancer Patients

January 16th 2012

New Indicator May Help Identify Patients With Increased Risk From Throat Cancer

January 16th 2012

Significant Cost Savings Associated With Emergence Of Prospective Surveillance Model As Standard Of Care For Breast Cancer Treatment

January 9th 2012

Early Palliative Care Improves Quality of Life in NSCLC

December 30th 2011

Johns Hopkins Gets More Than $8 Million to Further Cancer Research and Treatments

December 29th 2011

Following the Patient's Lead

December 28th 2011

ASCO Picks Top Advances in Cancer Treatment

December 28th 2011

Dr. Susan Urba Discusses Cost Concerns for Treatment of Chemotherapy-Induced Nausea

December 22nd 2011

Dr. Susan Urba Discusses Preventive Care for Patients With Chemotherapy-Induced Nausea

December 22nd 2011

Cost Savings in Inpatient Oncology Through an Integrative Medicine Approach

Benjamin Kligler, MD, MPH;Peter Homel, PhD;Louis B. Harrison, MD;Hanniel D. Levenson, MS;Jeanne B. Kenney, RN, BSN, HN-BC;Woodson Merrell, MD

December 22nd 2011

An approach including yoga, holistic nursing, and a "healing environment" can decrease medication use, resulting in substantial cost savings in care of inpatient oncology patients.

Cancer Vaccines: New Approaches

December 21st 2011

Cancer Screening May Be Overdone in Older Adults

December 15th 2011

American Cancer Society Changes Its Screening Guideline Process

December 14th 2011

Breast Cancer Survivors Prefer Oncologist Follow-Up

December 13th 2011

ONC Pushing for Standards to Increase Interoperability

December 12th 2011

Dr. Ravi Vij Discusses Benefits/Efficacy of Carfilzomib and Revlimid

December 6th 2011